Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab
Authors
Keywords
Adult T-cell lymphoma/leukemia, CCR4, Mogamulizumab, Colitis, Immune-related adverse event
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 102, Issue 4, Pages 493-497
Publisher
Springer Nature
Online
2015-05-20
DOI
10.1007/s12185-015-1811-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
- (2014) Michinori Ogura et al. JOURNAL OF CLINICAL ONCOLOGY
- Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
- (2014) Kenji Ishitsuka et al. LANCET ONCOLOGY
- Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma
- (2013) Takashi Ishida et al. CANCER SCIENCE
- Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab
- (2013) Nobuaki Nakano et al. HEPATOLOGY RESEARCH
- Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma
- (2013) Koji Kato et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Multifocal radiculoneuropathy during ipilimumab treatment of melanoma
- (2013) Georgios Manousakis et al. MUSCLE & NERVE
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Severe meningo-radiculo-nevritis associated with ipilimumab
- (2012) Flavie Bompaire et al. INVESTIGATIONAL NEW DRUGS
- Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
- (2012) Hiroo Katsuya et al. JOURNAL OF CLINICAL ONCOLOGY
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-CTLA-4 antibody-induced Guillain-Barre syndrome in a melanoma patient
- (2011) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
- (2010) T. Ishii et al. CLINICAL CANCER RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graft-versus-host disease
- (2009) James LM Ferrara et al. LANCET
- Digestive histopathological presentation of IPEX syndrome
- (2008) Natacha Patey-Mariaud de Serre et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started